Friday 6 November 2026 Export BMY’s income statement to Excel — free account

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024.

Revenue: +6.93%
EPS: −2.02%
Free cash flow: −36.0%
Total debt: −12.5%

Quarter to September 2026, against a year earlier

62.46 0.67 −1.06%

Follow BMY

Alert me

Market cap: $129.0B
P/E: 14.0×
Fwd P/E: 11.9×
Dividend yield: 3.99%
F-score: 8/9
Altman Z: 2.14
Beneish M: −2.69
Dividend safety: 63/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Bristol Myers Squibb Company (BMY) Current ratio

Alert me on Current ratio

Bristol Myers Squibb Company's current ratio at the end of the quarter to 30 September 2026 was 1.6×, up 0.3× from fiscal 2025 (1.3×). Over the past ten years it has ranged from 1.2× (fiscal 2022) to 1.7× (fiscal 2018); the current reading is higher than 27% of that period. That is above the Drug Manufacturers General industry median of 1.4× and below the Healthcare sector median of 3.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BMY/current-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Bristol Myers Squibb Company current ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BMY/metrics/current-ratio">Bristol Myers Squibb Company (BMY) current ratio — stockrow.com</a></p>

Period	Current ratio	Change
FY2025	1.3×	0.20%
FY2024	1.3×	(12.23%)
FY2023	1.4×	14.54%
FY2022	1.2×	(18.09%)
FY2021	1.5×	(3.88%)
FY2020	1.6×	(1.33%)
FY2019	1.6×	(3.55%)
FY2018	1.7×	7.05%
FY2017	1.6×	0.21%
FY2016	1.6×	19.32%

Period	Current ratio	Change
Sep 2026	1.6×	3.64%
Jun 2026	1.5×	7.84%
Mar 2026	1.4×	13.15%
Dec 2025	1.3×	(0.88%)
43 more quarters	Free account

Against its own ten years

Low 1.2× High 1.7×

Ten-year median 1.5×

Current reading's percentile 27

Company	Current ratio
BMY Bristol Myers Squibb Company	1.6×
AMGN Amgen Inc. compare	1.5×
PFE Pfizer Inc. compare	1.4×
GILD Gilead Sciences, Inc. compare	1.4×
SNY Sanofi compare	1.1×
AZN AstraZeneca PLC compare	1.0×
NVS Novartis AG compare	0.9×
NVO Novo Nordisk A/S compare	0.9×
GSK GSK PLC Sponsored ADR compare	0.9×
Drug Manufacturers General industry median	1.4×
Healthcare sector median	3.1×
Market median	1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

Bristol Myers Squibb Company (BMY) Current ratio

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on BMY

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on BMY

Stockrow Weekly